Insider Transactions in Q4 2021 at Arbutus Biopharma Corp (ABUS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2021
|
Michael J. Sofia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
200,000
-13.3%
|
$1,000,000
$5.09 P/Share
|
|
Oct 18
2021
|
Roivant Sciences Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
22,833,922
+37.02%
|
-
|